Monensin

Decoquinate:12.9 to 90.8 g/ton and Monensin: 5 to 30 g/ton

Feed as sole ration to provide 22.7 milligrams of decoquinate per 100 lbs of body weight per day and 50 to 360 milligrams of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard. Do not feed to cows producing milk for human consumption. A withdrawal period has not been established for this product in pre-ruminant calves. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds are safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusal and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for the control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to lincomycin in broiler chickens up to 16 weeks of age. Not for use in laying hens, breeder chickens, or turkeys.

90 to 110 g/ton monensin and 2 g/ton lincomycin (as lincomycin hydrochloride agricultural grade) in Type C medicated feed. Feed as the sole ration.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima and for increased rate of weight gain and improved feed efficiency in broiler chickens.

Monensin, 90 to 110 grams per ton of feed. Bacitracin (as feed grade bacitracin zinc), 4 to 50 grams per ton of feed. Feed as the sole ration.

For increased rate of weight gain, improved feed efficiency, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

Ractopamine hydrochloride top dress (not to exceed 800g/ton) plus monensin USP (10 to 40 g/ton).

For increased rate of weight gain, improved feed efficiency, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine is fed continuously as the sole ration at a concentration of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed to provide 90 to 430 mg/hd/day ractopamine/head/day.

Monensin is added to the ration at a concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day of monensin for the last 28 to 42 days on feed.

Melengestrol acetate supplements (liquid and dry):

Must be top dressed or mixed with a complete ration containing ractopamine (9.8 to 24.6 g/ton) and monensin (10 to 40 g/ton). Feed at the rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal. 

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton)

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) plus monensin sodium (10 to 40 g/ton) in combination with tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal. 

Liquid Type B Medicated Feeds must bear the following caution: 

Inadequate mixing (recirculation or agitation) of monensin liquid Type B medicated feed has resulted in increased monensin concentration, which has been fatal to cattle. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine is fed at concentrations of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed (based on 90% dry matter basis) to provide 90 to 430 mg ractopamine/head/day in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day. Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day in heifers being fed for slaughter.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to E. bovis and E. zuernii and reduction in incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin in combination with 8 to 10 g/ton tylosin phosphate.

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g monensin USP per ton of complete feed to provide 0.14 to 0.42 mg monensin/lb of body weight/day, depending on severity of coccidiosis challenge, up to a maximum of 480 mg monensin/head/day.

Tylosin is added to the cattle diets at concentrations of 8 to 10 g tylosin phosphate per ton complete feed to provide 60 to 90 mg tylosin/head/day.

Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day in heifers fed in confinement for slaughter. Feed melengestrol acetate in this combination for the final 28 to 42 days.

Feed continuously as sole ration during the last 28 to 42 days on feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

For increased rate of weight gain.

Blocks to be fed free choice. Provide at least one block per five head of cattle. Feed blocks continuously. Discontinue feeding if block consumption falls below 2 oz. or rises above 8 oz daily. Do not feed salt or mineral supplements in addition to the blocks. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result

For improved feed efficiency and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. maxima and E. mivati .

Monensin, 90 to 110 grams per ton of feed, plus bacitracin methylene disalicylate, 4 to 50 grams per ton of feed.

Do not fed to laying chickens. Feed continuously as sole ration. In the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. As monensin sodium.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and for the control of complicated chronic respiratory disease (CRD or air-sac infection) caused by Mycoplasma gallisepticum and Escherichia coli in broiler chickens.

90 or 110 grams monensin and 200 grams oxytetracycline per ton of Type C medicated feed.

Feed continuously as sole ration. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses andguinea fowl has been fatal. In the absence of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and as an aid in the reduction of mortality due to air-sacculitis (air-sac infection) caused by Escherichia coli sensitive to oxytetracycline in broiler chickens.

90 to 110 grams monensin and 500 grams oxytetracycline per ton of Type C medicated feed.

Feed for 5 days as the sole ration. Treat at first clinical signs of disease. Withdraw 72 hours before slaughter. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not use in low-calcium feed containing less than 0.55% dietary calcium. Use in such feeds may result in violative residues. Do not allow horses other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of cocciodiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced weight gain. Not for replacement chickens intended to become breeding chickens.

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter.

13.6 to 27.2 grams decoquinate per ton and 5 to 30 grams monensin per ton and 8 to 10 grams tylosin per ton.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.Feed only to cattle fed in confinement for slaughter. Feed continuously as the sole ration to provide 22.7 mg of decoquinate per 100 lb body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg of tylosin per head per day. Feed at least 28 days during period of exposure to coccidiosis or when it is likely to be a hazard. Bentonite should not be used in decoquinate feeds. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain and improved feed efficiency.

Monensin, 90 to 110 grams per ton of feed plus bambermycins, 1 to 2 grams per ton of feed.

Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. 

Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Melengestrol acetate (0.125 to 1. 0 mg/lb is top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton), and zilpaterol (6.8 g/ton).

Feed continuously as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. 

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole rotation containing 9.8 to 24.6 grams/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; combined with monensin 10 to 40 grams per ton to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day; tylosin 8 to 10 grams per ton to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 milligrams per head per day for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Ractopamine HCl is not for animals intended for breeding. 

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds storedin recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tankto the top. Recirculate daily, as directed in this paragraph evenwhen the Type C feed is not used." For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems:“Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Please see NADA 125-476 for more information

Please see NADA 125-476 for more information

Please see NADA 125-476 for more information

Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin per ton of complete feed at a rate of 0.14 mg to 0.42 mg monensin per pound of body weight depending on the severity of coccidiosis challenge up to 480 mg per head per day.

Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin per head per day.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration. A withdrawal time has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat),prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii,reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. 

Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, and for prevention and control of coccidiosis caused by Eimeria bovis and E. zuernii in growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture which may require supplemental feed.

MoorMan's® Mintrate® Blonde Block RU is for growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture when maintained on good quality pasture or roughage. If the pasture is in short supply or poor quality, Mintrate Red Block RU is recommended. Before feeding, be sure cattle are accustomed to protein blocks by feeding unmedicated Mintrate Blocks for 30 to 60 day or until cattle have demonstrate ed proper consumption. As soon as cattle have demonstrated proper consumption, remove the non-medicated blocks and replace with the amount of Mintrate Blonde Block RU. Feed this block free-choice. Do not allow animals access to other protein blocks, salt or mineral while being fed this product. Recommended consumption of block is 0.34 to 1.33 lb per head per day to provide 50 to 200 mg monensin per head per day. A 10-day supply of blocks may be put out at one time. Place blocks near water or loafing areas. Not less than one block for each 10 to 12 animals is recommended. Additional blocks should be put out when the current blocks are 75% consumed.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.

Feed a minimum of 1.0 lb/hd/day continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day (depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg/hd/day tylosin. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration to provide 90 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and for suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine HCl is not for animals intended for breeding.

Special considerations:

Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

For improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle being fed in confinement for slaughter.

Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg monensin/head/day.Monensin is added to feedlot cattle diets at concentrations of 5 to 40 g of monensin USP per ton of complete feed for improved feed efficiency to provide 50 to 480 mg monensin/head/day.Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.

Feed continuously to cattle during the last 20 to 40 dayson feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Special considerations:1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Complete feed: 6.8 g/ton zilpaterol to provide 60 to 90 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine.Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

Zilpaterol hydrochloride is fed at a concentration of 6.8 g of zilpaterol hydrochloride per ton of complete feed to provide 60 to 90 mg zilpaterol/head/day in cattle fed in confinement for slaughter during the last 20 to 40 days on feed.

Monensin USP is added to diets for cattle fed in confinement for slaughter at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. 

Tylosin phosphate is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Do not use in calves to be processed for veal. Feed continuously as the sole ration during the last 20 to 40 days on feed. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations:

1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.

2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 3.8 to 7.5. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. 

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

Monensin, 73 grams per ton

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef steers and heifers fed in confinement for slaughter.

Feed as the sole ration to provide 22.7 mg of decoquinate per 100 lb. of body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg tylosin (as tylosin phosphate). Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.

For reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

500 grams chlortetracycline and 90 to 110 grams monensin per ton of Type C medicated feed.

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii and improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.

12.9 to 90.8 g/ton of decoquinate and 5 to 30 g/ton of monensin. Feed as the sole ration to provide 22.7 of mg decoquinate per 100 lb of body weight per day and 50 to 360 mg of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day; 1.25 to 4.54 g/ton of lubabegron (as Experior™) to provide 13 to 90 mg lubabegron per head per day; and 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin. Feed as the sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day; 1.25 to 4.54 g/ton of lubabegron (as Experior™) to provide 13 to 90 mg lubabegron per head per day; 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day; and 8 to 10 g/ton of tylosin (as Tylovet®) to provide 60 to 90 mg tylosin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb per head per day) must be trop dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.

For reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

500 grams chlortetracycline and 90 to 110 g monensin per ton of Type C medicated feed. Feed for five days as the sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. In the absences of coccidiosis in broiler chickens, use of monensin with no withdrawal period may limit feed intake, resulting in reduced gains. Not to be fed for more than 5 days. Do not feed to chickens over 16 weeks of age.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding as sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding as sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain and improved feed efficiency, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed when ractopamine hydrochloride is used as a top dress with rations containing monensin and virginiamycin.

8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 400 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed a minimum of 1.0 lb per head per day of this Type C top-dress medicated feed during the last 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed.

8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 430 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding as a sole ration during the last 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter during the last 28 to 42 days on feed.

9.8 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 90 to 430 mg/head/day ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding as a sole ration during the last 28 to 42 days on feed.

For increased rate of weight gain and improved feed efficiency, and for the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis in growing turkeys.

4 to 50 g/ton of bacitracin (as Pennitracin MD®) and 54 to 90 g/ton of monensin (as Coxidin®). Feed continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

For the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter.

10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding.

For improved feed efficiency and reduction of incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter.

5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.

Feed at every feeding.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima; and for increase in rate of weight gain and improved feed efficiency in broiler chickens.

90 to 110 g/ton of monensin (as Coxidin®) and 5 to 25 g/ton of bacitracin (as BMD®). Feed this complete Type C medicated feed as the sole ration.

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and for increased rate of weight gain and improved feed efficiency in growing turkeys.

54 to 90 g/ton of monensin and 4 to 50 g/ton of bacitracin (as BMD®). Feed this complete Type C medicated feed as the sole ration.

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and as an aid in the control for transmissible enteritis in growing turkeys complicated by organisms susceptible to bacitracin methylenedisalicylate.

54 to 90 g/ton of monensin (as Coxidin®) and 200 g/ton of bacitracin (as BMD®). Feed this complete Type C medicated feed as the sole ration.

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and for improved feed efficiency in growing turkeys.

54 to 90 g/ton of monensin (as Coxidin®) and 1 to 2 g/ton of bambermycins (as Flavomycin®). Feed this complete Type C medicated feed as the sole ration.

For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis; and for increased rate of weight gain and improved feed efficiency in growing turkeys.

54 to 90 g/ton of monensin (as Coxidin®) and 2 g/ton of bambermycins (as Flavomycin®). Feed this complete Type C medicated feed as the sole ration.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain and improved feed efficiency.

1 to 2 g/ton of bambermycins (as Flavomycin®) and 90 to 110 g/ton of monensin (as Coxidin®). Feed this complete Type C medicated feed as the sole ration.

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens; and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima, in broiler chickens.

13.6 to 40.9 g/ton of avilamycin (as Inteprity™) and 90 to 110 g/ton of monensin (as Coxidin®). Feed this complete Type C medicated feed as the sole ration for 21 consecutive days.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and improved feed efficiency in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day, 1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg lubabegron per head per day, and 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day.
The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin. Feed as the sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain, improved feed efficiency, suppression of estrus heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef heifers fed in confinement for slaughter during the last to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day, 1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg lubabegron per head per day, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day, and 8 to 10 g/ton of tylosin (as tylosin phosphate) (as Tylan™) to provide 60 to 90 mg tylosin per head per day.

The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.

Feed continuously in a complete feed 5 to 40 g/ton monensin on a 90% dry matter basis to provide 50 to 480 mg monensin per head per day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed continuously 10 to 40 g/ton to provide 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg of monensin per head per day.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed at a rate of 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed continuously at 50 to 200 mg per head per day. Blend into a minimum of 1 pound of Type C medicated feed and either hand feed or mix into the total ration. Feed (other than the Type C medicated feed containing Rumensin) can be restricted to 95% (of normal requirements) when 50 mg of monensin activity is fed, and to 90% at 200 mg. Cows on pasture or in dry lot must receive a minimum of 1 pound of Type C medicated feed per head per day. Additionally, a minimum of 16 pounds (air-dry basis) of roughage such as silage, haylage, ammoniated straw, hay or equivalent feedstuffs should be fed in order to meet NRC recommendations for beef cows to gain 0.25 to 0.75 pounds per head per day. Standing, dried winter range forage may not be of adequate quality to result in improved e¬fficiency when supplemented with Rumensin. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

For the prevention of coccidiosis caused by Eimeria crandallis, Eimeria christenseni, and Eimeria ninakohlyakimovae.

20 grams per ton of complete feed continuously as the sole ration.

Feed only to goats maintained in confinement. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton. 

During the first 5 days, cattle should receive 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed at a rate of 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed OR at a rate of 400 mg monensin per head per day every other day in a minimum of 2 pounds of Type C medicated feed.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

For coccidiosis prevention and control

Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge. During the first 5 days, cattle should receive a maximum of 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed up to a maximum of 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Type C free-choice medicated feeds 

10 to 200 grams per ton of feed to provide 0.14 to 1.00 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg of monensin per head per day.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Total Mixed Ration (complete feed): Feed continuously 11 to 22 g/ton monensin on a 100% dry matter basis.

Component Feeding Systems (including top dress): Feed continuously 11 to 400 g/ton monensin in a minimum of 1 pound Type C medicated feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. You may notice reduced voluntary feed intake in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. Rule out monensin as the cause of reduced feed intake before attributing to other causes such as illness, feed management, or the environment. You may notice reduced milk fat percentage in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. You may notice increased incidence and treatment of cystic ovaries and metritis, reduced conception rates, increased services per animal, and extended days open and corresponding calving intervals in dairy cows fed monensin. Have a comprehensive and ongoing nutritional, reproductive and herd health program in place when feeding monensin to dairy cows.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicatedfeed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Inadequate mixing (recirculation or agitation) of monensin liquid Type C medicated feed has resulted in increased monensin concentration, which has been fatal to cattle. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 200 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency.

33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for improved feed efficiency.

400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for improved feed efficiency.

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

For the reduction of the incidence of liver abscesses and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

For the reduction of the incidence of liver abscesses and for improved feed efficiency.

7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency.

50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement beef and dairy heifers.

400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 84 g/ton of monensin (as Monovet®). 

For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.

For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for increased rate of weight gain in replacement beef and dairy heifers.

400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 400 g/ton of monensin (as Monovet®). 

For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.

For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, ofmonensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima.

Feed complete feed (90 to 110 g/ton) continuously as the sole ration.

For the prevention of coccidiosis in turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis.

Feed complete feed (54 to 90 g/ton) continuously as the sole ration. The optimum level depends upon the severity of coccidiosis exposure.

For the prevention of coccidiosis in growing Bobwhite quail caused by Eimeria dispersa and E. lettyae.

Feed complete feed (73 g/ton) continuously as the sole ration.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and improved feed efficiency in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™

Feed continuously as sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™.

Feed continuously as sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).

0.25 to 2 g/ton (0.0000276 to 0.00022%) fed at a rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg/head/day of melengestrol acetate(as CycleGuard®). Feed continuously as sole ration.

For improved feed efficiency and prevention and control of coccidiosis due to Eimeria bovis and Eimeria
zuernii.

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration.

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter over 700 lbs.

0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter.

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of the coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in beef calves 2 months of age and older. 

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 1.00 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 200 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone. 

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter over 700 lbs.

0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

For the reduction of the incidence of liver abscesses and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter over 400 lbs.

70 mg/head/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.

For the reduction of the incidence of liver abscesses and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter over 400 lbs.

70 mg/head/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration. No additional improvement in feed efficiency has beenshown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter under 700 lbs.

350 mg/head/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.

For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline and for improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter under 700 lbs.

350 mg/head/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).

For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline and for the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in growing beef steers and heifers fed in confinement for slaughter.

350 mg/head/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement beef and dairy heifers.

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™), depending upon severity of challenge, to provide 50 to 100 mg/head/day of monensin. Feed in a minimum of 1 pound of Type C medicated feed as the sole ration for not more than 5 days. For replacement beef and dairy heifers not currently being fed monensin, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin, continue to feed monensin Type C medicated feed alone.

For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for increased rate of weight gain in replacement beef and dairy heifers.

10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 100 mg/head/day of monensin (as Rumensin™). Feed in a minimum of 1 pound of Type C medicated feed as the sole ration for not more than 5 days. For replacement beef and dairy heifers not currently being fed monensin, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin, continue to feed monensin Type C medicated feed alone.

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens; and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E.maxima in broiler chickens.

Administer 13.6 to 40.9 g avilamycin and 90 to 110 g monensin per ton of Type C medicated feed.

Feed this complete Type C medicated feed as the sole ration for 21 consecutive days. Feed to chickens that are at risk of developing, but not yet showing clinical signs of necrotic enteritis associated with Clostridium perfringens in broiler chickens. To assure responsible antimicrobial drug use in broiler chickens, treatment administration must begin on or before 18 days of age. The safety of avilamycin has not been established in chickens intended for breeding purposes. Avilamycin has not been demonstrated to be effective in broiler chickens showing clinical signs of necrotic enteritis prior to the start of medication. In the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. Not for broiler breeder replacement chickens. Do not feed to laying chickens. Do not feed to chickens over 16 weeks of age. Do not allow horses,equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal.

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration for 28 to 35 days, starting from the time chicks are placed for brooding. 

For increased rate of weight gain and improved feed efficiency, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.

4 to 50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration throughout the feeding period.

For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in laying hen replacement chickens and layer breeder replacement chickens.

50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration for 28 to 35 days, starting from the time chicks are placed for brooding.

For increased rate of weight gain and improved feed efficiency, and as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in laying hen replacement chickens and layer breeder replacement chickens.

4 to 50 g/ton of bacitracin (as feed grade bacitracin methylenedisalicylate provided by Pennitracin MD®) and 90 to 110 g/ton of monensin (as Coban™). Feed as the sole ration throughout the feeding period.

For increased rate of weight gain.

PASTURE GAINER BLOCK 20 R350 is a free-choice protein block containing 175 mg monensin per pound. Feed one block for every four (4) cattle. Place near watering or loafing areas in a well-drained area. Cattle should consume from 4.0 to 18.0 ounces (0.25 to 1.13 lb) per head per day to provide 40 to 200 mg monensin per head per day. Consumption of this block may vary with temperature and/or quality of forage. If consumption of the block is below 4.0 ounces per head per day, increase number of feeding locations or relocate the blocks to a more frequented area. Blocks should be replenished every 7 to 14 days. Do not allow cattle access to salt or minerals while being fed this block. Ingestion by cattle of monensin at levels of 600 mg per head per day and higher has been fatal. Do not allow horses or other equines access to feed containing monensin. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions; reduced average daily gains may result. Do not feed to sheep due to high levels of supplemental copper.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration to provide 50 to 480 monensin mg/hd/day and 60 to 90 tylosin mg/hd/day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylan™. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylan™. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin. 

For improved feed efficiency.

Feed complete feed (5 to 40 g/ton) continuously to growing finishing beef cattle to provide not less than 50 nor more than 480 mg monensin per head per day.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Feed continuously (10 to 40 g/ton) to provide 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg of monensin per head per day.

For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake).

Total Mixed Rations (“complete feed”): Feed continuously to dry and lactating dairy cows a total mixed ration ("complete feed") containing 11 to 22 g/ton monensin on a 100% dry matter basis.

Component Feeding Systems (including top dress): Feed continuously to dry and lactating dairy cows a Type C Medicated Feed containing 11 to 400 g/ton monensin. The Type C Medicated Feed must be fed in a minimum of 1 pound of feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.

For increased rate of weight gain.

Feed at the rate of not less than 50 nor more than 200 mg per head per day in not less than one pound of Type C Medicated Feed; or after the 5th day, feed at the rate of 400 mg per head per day every other day in not less than 2 pounds of Type C Medicated Feed. The monensin concentration in the Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.

Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

Feed at a rate to provide 0.14 to 0.42 mg per pound body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. The monensin concentration in Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.

Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.

For improved feed efficiency when receiving supplemental feed.